Loading publications…
The last 5 uploaded publications
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, Gar-Yang Chau, Jiamei Yang, Masatoshi Kudo, Jianqiang Cai, Ronnie T.P. Poon, Kwang–Hyub Han, Won Young Tak, Han Chu Lee, Tianqiang Song, Sasan Roayaie, Luigi Bolondi, Kwan Sik Lee, Masatoshi Makuuchi, Fabrício Henrique Pereira De Souza, Marie-Aude Le Berre, Gerold Meinhardt, Josep M. Llovet (2015). Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Oncology, 16(13), pp. 1344-1354, DOI: 10.1016/s1470-2045(15)00198-9.
Article145 days agoMolecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol, Robert Montal, Laia Bassaganyas, Daniela Sia, Tadatoshi Takayama, Gar-Yang Chau, Vincenzo Mazzaferro, Sasan Roayaie, Han Chu Lee, Norihiro Kokudo, Zhongyang Zhang, Sara Torrecilla, Agrin Moeini, Leonardo Rodríguez‐Carunchio, Edward Gane, Chris Verslype, Adina Croitoru, Umberto Cillo, Manuel de la Mata, L. Lupo, Simone I. Strasser, Joong‐Won Park, Jordi Camps, Manel Solé, Swan N. Thung, Augusto Villanueva, Carol Peña, Gerold Meinhardt, Jordi Bruix, Josep M. Llovet (2018). Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut, 68(6), pp. 1065-1075, DOI: 10.1136/gutjnl-2018-316408.
Article145 days agoSTORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC)
Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, Gar‐Yang Chau, Jiamei Yang, Masatoshi Kudo, Jianqiang Cai, Ronnie Tung‐Ping Poon, Kwang–Hyub Han, Won Young Tak, Han Chu Lee, Tianqiang Song, Sasan Roayaie, Luigi Bolondi, Kwan Sik Lee, Masatoshi Makuuchi, Fabrício Henrique Pereira De Souza, Marie‐Aude Le Berre, Gerold Meinhardt, Josep M. Llovet (2014). STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC). Journal of Clinical Oncology, 32(15_suppl), pp. 4006-4006, DOI: 10.1200/jco.2014.32.15_suppl.4006.
Article145 days agoGene Expression and Therapy
Agustı́n González, Tomás Rybertt, Juan Pablo Arab, Margarita Pizarro, Nancy Solı́s, Marco Arrese, Feng Huang, Dan Wang, Pu Chen, Ping Yang, Ju Cao, Ping Zhang, Yutaka Midorikawa, Shogo Yamamoto, Hiroki R. Ueda, Kotaro Sonoda, Shingo Tsuji, Kenji Tatsuno, Tatsuhiro Shibata, Kyle R. Covington, David A. Wheeler, Tadatoshi Takayama, Hiroyuki Aburatani, Daniela Sia, Bojan Losic, Kate Revill, Ke Hao, Laia Cabellos, Zhongyang Zhang, Yujin Hoshida, Sasan Roayaie, Swan N. Thung, Myron Schwartz, Samuel Waxman, Vincenzo Mazza- Ferro, Eric E. Schadt, Josep M. Llovet, Ana Alondra Sobrevilla-Navarro, Ana Sandoval-Rodríguez, Jesus Gar- Cia-Banuelos, Luis Daniel Hernández‐Ortega, José Macías‐Barragán, Juan Armendáriz‐Borunda, Adriana Salazar Montes, Zoe Raglow, Chuanghong Wu, Yu Wan, Khaleel Jamil, Kuldeep Cheent, Michael A. Heneghan, Marco A. Purbhoo, Salim I. Khakoo (2013). Gene Expression and Therapy. Hepatology, 58(S1), pp. 396A-412A, DOI: 10.1002/hep.26842.
Article145 days ago